Anti-CD20 Monoclonal Antibody (Rituximab) for the Treatment of Recurrent Idiopathic Membranous Nephropathy in a Renal Transplant Patient
Authors:
Open Access
- 16 November 2006
- journal article
- case report
- Published by Elsevier in American Journal of Transplantation
- Vol. 6 (12) , 3017-3021
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- New insights into the pathogenesis of membranous glomerulonephritisCurrent Opinion in Nephrology and Hypertension, 2006
- PresensitizationClinical Journal of the American Society of Nephrology, 2006
- Graft Loss from Recurrent Glomerulonephritis Is Not Increased with a Rapid Steroid Discontinuation ProtocolTransplantation, 2006
- Cellular Response to Injury in Membranous NephropathyJournal of the American Society of Nephrology, 2005
- Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathyRheumatology, 2005
- Why study membranous nephropathy in rats?Kidney International, 2003
- Recent developments in the management of membranous nephropathyExpert Opinion on Investigational Drugs, 1997
- A review of therapeutic studies of idiopathic membranous glomerulopathyAmerican Journal of Kidney Diseases, 1995
- Membranous NephropathyAnnals of Internal Medicine, 1992
- DE NOVO AND RECURRENT MEMBRANOUS GLOMERULOPATHY FOLLOWING KIDNEY TRANSPLANTATIONTransplantation, 1983